QHQinchao Hu

Qinchao Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qinchao Hu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Cheng

    Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

    6 shared publications
  • Jianmin Peng

    Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

    3 shared publications
  • Huan Li

    State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China

    2 shared publications
  • Huan Li

    Administration Department of Nosocomial Infection, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China; Department of Intensive Care Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China

    2 shared publications
  • Jianmin Peng

    Hospital of Stomatology Sun Yat‐sen University Guangzhou China

    2 shared publications
  • Jiayu Zhang

    Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

    2 shared publications

Latest Publications

  • Open Access

    Uncovering a novel treatment strategy: sodium butyrate overcomes cisplatin resistance in the oral squamous cell carcinoma by inducing ferroptosis

    by Bing Wang, Wei Li, Yujia Bai, Zhangci Su, Qingwen Zeng, Chao Lv, Qinchao Hu, Bin Cheng, Xiaoan Tao

    Background: Chemoresistance to platinum-based agents like cisplatin is a major therapeutic challenge in advanced oral squamous cell carcinoma (OSCC), with 70–80% of recurrent cases developing resistance that severely compromises clinical outcomes. The mechanism of cisplatin resistance still remains unclear and requires further investigation. This study investigated ferroptosis suppression as a mechanism underlying this resistance and explored the therapeutic potential of the histone deacetylase (HDAC) inhibitor sodium butyrate (NaB). Methods: Cisplatin-resistant OSCC cells (CAL27/CDDP) and parental cells (CAL27) were used to assess ferroptosis levels and resistance mechanisms. The effects of NaB on reversing cisplatin resistance and inhibiting malignant behaviors (proliferation, migration, invasion) were evaluated in vitro. Mechanistic studies, including identification of key regulators and epigenetic modifications were conducted. The therapeutic effect was further validated in vivo using xenograft tumor models treated with NaB and cisplatin. Results: CAL27/CDDP exhibited significant ferroptosis suppression compared to CAL27. NaB effectively reversed cisplatin resistance and inhibited malignant behaviors in both cell lines. Mechanistic exploration revealed that NaB enhanced acetylation at the promoter region of early growth response protein 1 (EGR1) through HDAC9 inhibition, elevating its transcriptional activity. EGR1 functioned as a transcription factor to upregulate cytochrome P450 oxidoreductase (POR) expression, potentiating ferroptosis execution. In vivo experiments further confirmed the therapeutic relevance of this HDAC9/EGR1/POR signaling pathway, as NaB administration significantly sensitized xenograft tumors to cisplatin treatment. Conclusions: These findings position NaB as a promising epigenetic modulator for overcoming cisplatin resistance in OSCC models, with immediate clinical implications. The identified pathway offers a redox biology-based therapeutic strategy that could be extended to other chemotherapy-resistant solid tumors, potentially revolutionizing the treatment paradigm for recurrent malignancies.


  • Open Access

    Perilipin2-dependent lipid droplets accumulation promotes metastasis of oral squamous cell carcinoma via epithelial-mesenchymal transition

    by Jiayu Zhang, Jianmin Peng, Siyu Wang, Li Wang, Yutong Sun, Juan Xia, Bin Cheng, Qinchao Hu

    Emerging evidence shows that lipid metabolic reprogramming plays a vital role in tumor metastasis. The effect and mechanism of fatty acids and lipid droplets (LDs), the core products of lipid metabolism, on the metastasis of oral squamous cell carcinoma (OSCC), need further exploration. In this study, the influence of palmitic acid (PA) and oleic acid (OA) on the migration and invasion ability of OSCC cells was determined by in vitro experiments. Genetic manipulation of PLIN2 was performed to explore its effect on the accumulation of LDs and OSCC metastasis. Possible mechanisms of these biological effects were clarified by detecting the levels of epithelial-mesenchymal transition (EMT) markers and phosphatidylinositol 3-kinase (PI3K) pathway proteins as well as conducting various bioinformatics analyses. The results indicated that PA/OA promoted the migration and invasion of OSCC cells and induced PLIN2-dependent LDs accumulation in vitro. Knockdown of PLIN2 inhibited the LDs accumulation and the migration and invasion of OSCC cells in vitro, while overexpression of PLIN2 enhanced those of OSCC cells in vitro and also promoted the metastasis of OSCC in vivo. Besides, PLIN2 up-regulation activated the PI3K pathway and subsequently enhanced EMT in OSCC cells in vitro. OSCC patients with higher PLIN2 expression possessed poorer prognosis and higher sensitivity to chemotherapy drugs (1S,3 R)-RSL3 and ML-210. In conclusion, PLIN2-dependent LDs accumulation could promote the metastasis of OSCC cells by regulating EMT. PLIN2 might be a potential therapeutic target for OSCC patients, especially those with obesity.


  • Radiotherapy upregulated immune checkpoints contribute to the development of second primary OSCC

    by Li Wang, Siyu Wang, Jiayu Zhang, Jianmin Peng, Bin Cheng, Huan Li, Qinchao Hu

    Objectives: Radiation injury is common after radiotherapy for head and neck cancer. Radiotherapy can reshape the immune microenvironment and cause immunosuppression, including dysregulation of immune checkpoints (ICs). However, the relationship between oral ICs expression after radiation and the development of second primary tumors is unclear.Methods: Clinical specimens of second primary oral squamous cell carcinoma after radiotherapy (s‐OSCC) and primary OSCC (p‐OSCC) were collected. The expression and prognostic value of PD‐1, VISTA, and TIM‐3 were analyzed using immunohistochemistry. To further clarify the relationship between radiation and ICs alteration, a rat model was constructed to explore the spatiotemporal changes of ICs in the oral mucosa after radiation.Results: In carcinoma tissue, the expression of TIM‐3 was higher in s‐OSCC than in p‐OSCC, while the expression of PD‐1 and VISTA was similar between the groups. In para‐carcinoma tissue, the expression of PD‐1, VISTA, and TIM‐3 was higher in s‐OSCC. High ICs expression was associated with poor survival. In the rat model, ICs were locally upregulated in the irradiated tongue. Moreover, there was a bystander effect, in which the ICs were also upregulated in the unirradiated site.Conclusion: Radiation may upregulate ICs expression in oral mucosa and contribute to the development of s‐OSCC.


  • Correlation analysis of plasma lipid profiles and the prognosis of head and neck squamous cell carcinoma

    by Siyu Wang, Li Wang, Huan Li, Jiayu Zhang, Jianmin Peng, Bin Cheng, Ming Song, Qinchao Hu

    Purpose: This study aims to clarify whether blood lipid profiles are indicators of prognosis in patients with head and neck squamous cell carcinoma (HNSCC).Methods: This retrospective study included 512 T1/2N0M0 HNSCC patients. The correlation between blood lipid profiles and progression‐free survival (PFS) and disease‐specific survival (DSS) was analyzed by multivariate analysis. The data from TCGA was also analyzed to investigate the expression levels and prognostic values of different lipoprotein receptors essential for specific lipid uptake.Results: A high level of low‐density lipoprotein cholesterol (LDL‐C) indicated better PFS and DSS, and a low level of apolipoprotein A‐I (Apo A‐I) indicated better PFS, while a high level of apolipoprotein B (Apo B) indicated poorer PFS and DSS. The Apo A‐I receptor gene SCARB1 was upregulated and associated with poor survival in HNSCC patients. Activation of SCARB1 was implicated in a series of tumor‐promoting pathways. There was no significant correlation between the expression of LDL‐C and Apo B‐related receptors and prognosis.Conclusion: A high level of LDL‐C and a low level of Apo A‐I are protective factors for HNSCC, while a high level of Apo B is a risk factor. The upregulation of SCARB1 may participate in the progression of HNSCC.


  • Open Access

    Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells

    by Jianmin Peng, Qinchao Hu, Xijuan Chen, Chunyang Wang, Jiayu Zhang, Xianyue Ren, Yun Wang, Xiaoan Tao, Huan Li, Ming Song, et al.

    Although obesity has been associated with an increased risk and aggressiveness of many types of carcinoma, whether it promotes squamous cell carcinoma remains unclear. To reveal the role of obesity in oral squamous cell carcinoma (OSCC) initiation and development, we used 4NQO-induced OSCC model mice to examine the impact of dietary obesity on carcinogenesis. The results showed that high-fat diet (HFD)-induced obesity significantly promoted the incidence of OSCC and altered the local immune microenvironment with the expansion of CD11b+Gr1+myeloid-derived suppressor cells (MDSCs). The underlying mechanism that induced an immunosuppressive local microenvironment in obesity was the recruitment of MDSCs through the CCL9/CCR1 axis and enhancement of MDSC immunosuppressive function via intracellular fatty acid uptake. Furthermore, clinical samples verified the increase in infiltrated CD33+(a marker of human MDSCs) cells in obese OSCC patients, and data from the TCGA dataset confirmed that CD33 expression was positively correlated with local adipocytes in OSCC. Survival analysis showed that enrichment of adipocytes and high expression of CD33 were associated with poor prognosis in OSCC patients. Strikingly, depletion of MDSCs significantly ameliorated HFD-promoted carcinogenesis in 4NQO-induced model mice. These findings indicate that obesity is also an important risk factor for OSCC, and cancer immunotherapy, especially targeting MDSCs, may exhibit greater antitumor efficacy in obese patients.


  • Open Access

    The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation

    by Qinchao Hu, Tong Wu, Xiaobing Chen, Huan Li, Zhicheng Du, Yuantao Hao, Jianmin Peng, Shanshan Tai, Ming Song, Bin Cheng

    Radiotherapy for nasopharyngeal carcinoma has been reported to cause second primary oral squamous cell carcinoma (s‐OSCC). The prognosis and pathologic characteristic of s‐OSCC are largely unknown. Bmi1 was associated with the repair of radiation‐induced DNA damage, suggesting its possible involvement in the pathologic process of s‐OSCC. Herein, we compared the prognosis between s‐OSCC and primary OSCC (p‐OSCC) and explored the involvement of Bmi1 in s‐OSCC development. In this retrospective study, s‐OSCC and p‐OSCC patients were matched by propensity scores. Their outcomes were compared by univariate and multivariate analyses. The expression of Bmi1 in s‐OSCC and p‐OSCC was detected by immunohistochemistry (IHC). Radiation‐induced Bmi1 alteration in early‐stage was explored in a rat model and HaCaT cells. After matching, 116 pairs of patients with highly balanced characteristics were included. In univariate analysis, the overall survival (OS), disease‐specific survival (DSS), and local recurrence‐free survival (LRFS) were poorer in s‐OSCC than in p‐OSCC (P < 0.05), while their regional metastasis‐free survival (RMFS) was parallel (P = 0.112). Multivariate analysis further revealed that radiotherapy history was an independent risk factor for OS, DSS, and LRFS (P < 0.05). IHC results showed that the positive rate of Bmi1 was higher in s‐OSCC (P = 0.0027). In a rat model of radiotherapy‐induced mucositis, Bmi1 upregulation was observed 8 days after irradiation. Consistently, Bmi1 was upregulated in HaCaT cells 1 h after irradiation, and its upregulation was in accord with X‐ray exposure duration. In conclusion, the prognosis of s‐OSCC is poorer as compared to p‐OSCC, which may be attributed to Bmi1 upregulation.